Clinical Drug Experience Knowledgebase

Acute Chest Syndrome (Phase 3)

Adenocarcinoma (Phase 2)

Adenomatous Polyposis Coli (Phase 3)

Aggression (Phase 2)

Alcoholism (Phase 4)

Alzheimer Disease (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Anemia, Refractory (Phase 3)

Anemia, Refractory, with Excess of Blasts (Phase 3)

Arthritis (Phase 2)

Arthritis, Psoriatic (Phase 2)

Atrial Fibrillation (Phase 4)

Bile Duct Neoplasms (Phase 2)

Brain Neoplasms (Phase 3)

Breast Neoplasms (Phase 3)

Bronchiolitis (Phase 3)

Bronchiolitis Obliterans (Phase 3)

Burkitt Lymphoma (Phase 2)

Burns (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Ductal (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiovascular Diseases (Phase 3)

Cholangiocarcinoma (Phase 3)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 2)

Coronary Artery Disease (Phase 3)

Coronavirus Infections (Phase 1)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Disease (Phase 3)

Fibrosis (Phase 4)

Foot Ulcer (Phase 4)

Gallbladder Neoplasms (Phase 3)

Genital Diseases, Female (Phase 4)

Genital Diseases, Male (Phase 4)

Glioblastoma (Phase 3)

Graft vs Host Disease (Phase 3)

Head and Neck Neoplasms (Phase 3)

Heart Diseases (Phase 3)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 4)

Hemangiosarcoma (Phase 2)

Hemorrhagic Fever, Ebola (Phase 1)

Hemorrhagic Fevers, Viral (Phase 1)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

HIV Infections (Phase 2)

Infarction (Phase 3)

Infections (Phase 2)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Intermittent Claudication (Phase 2)

Ischemia (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Liver Cirrhosis (Phase 4)

Lung Neoplasms (Phase 2)

Lymphohistiocytosis, Hemophagocytic (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Medulloblastoma (Phase 3)

Melanoma (Phase 3)

Metabolic Syndrome (Phase 3)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Nasopharyngeal Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms, Plasma Cell (Phase 2)

Neurofibroma (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Obesity (Phase 4)

Opioid-Related Disorders (Phase 3)

Oropharyngeal Neoplasms (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Hip (Phase 2)

Pancreatic Neoplasms (Phase 3)

Peripheral Arterial Disease (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Sclerosis (Phase 2)

Shock (Phase 3)

Shock, Cardiogenic (Phase 3)

Sleep Disorders, Circadian Rhythm (Phase 3)

Sleep Wake Disorders (Phase 3)

Stomach Neoplasms (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Uveal Neoplasms (Phase 3)

Virus Diseases (Phase 1)